Utama › Fibrosis Paru Idiopatik › Michigan
Kajian klinikal Fibrosis Paru Idiopatik di Michigan
7 kajian untuk Fibrosis Paru Idiopatik sedang mencari peserta di lokasi di Michigan.
Bandar di Michigan
Teks kajian rasmi (Bahasa Inggeris)
A Phase IIb Study to Evaluate AZD8965 in Participants With IPF.
- Research Site, Ann Arbor
- Research Site, Detroit
Mengambil pesertaFasa 2
Umur 40 ke atas · Semua jantina · Dikemas kini 21 Sep 2026 · NCT07652658RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
- University of Michigan, Ann Arbor
- Henry Ford Health, Novi
Mengambil pesertaFasa 2
Umur 18 hingga 80 · Semua jantina · Dikemas kini 15 Sep 2026 · NCT07002034A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis
- Henry Ford Health, Detroit
Mengambil pesertaFasa 2
Umur 40 ke atas · Semua jantina · Dikemas kini 4 Sep 2026 · NCT06968845Study of ABBV-142 to Assess Adverse Events and Change in Disease Activity in Adult Participants With Idiopathic Pulmonary Fibrosis
- University of Michigan Health System - Ann Arbor /ID# 279994, Ann Arbor
- Henry Ford Hospital /ID# 277843, Detroit
Mengambil pesertaFasa 2
Umur 40 ke atas · Semua jantina · Dikemas kini 3 Sep 2026 · NCT07230288Oral Ifetroban in Patients With Idiopathic Pulmonary Fibrosis (IPF)
- Beaumont Hospital, Royal Oak, Royal Oak
Mengambil pesertaFasa 2
Umur 40 ke atas · Semua jantina · Dikemas kini 2 Sep 2026 · NCT05571059Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry
- Henry Ford Health, Detroit
Mengambil pesertaKajian pemerhatian
Umur 21 ke atas · Semua jantina · Dikemas kini 12 Ogo 2026 · NCT01915511WISPer: Evaluation of MTX-463 in Participants With Idiopathic Pulmonary Fibrosis (IPF)
- WISPer Site in Ann Arbor, MI, Ann Arbor
- WISPer Site in Detroit, MI, Detroit
Mengambil pesertaFasa 2
Umur 40 ke atas · Semua jantina · Dikemas kini 10 Ogo 2026 · NCT06967805Daripada ClinicalTrials.gov, data diperoleh pada 6 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.